Cite
HARVARD Citation
Zeng, W. et al. (2022). Engineering Novel CD19/CD22 Dual-Target CAR-T Cells for Improved Anti-Tumor Activity. Cancer investigation. pp. 282-292. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Zeng, W. et al. (2022). Engineering Novel CD19/CD22 Dual-Target CAR-T Cells for Improved Anti-Tumor Activity. Cancer investigation. pp. 282-292. [Online].